Hematology
Latest News
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
“The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available...
Feature
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
From the Journals
Inflammation, thrombosis biomarkers tied to COVID-19 deaths
“Of particular interest is the finding that over three quarters of critically ill patients required a ventilator and almost one third required...
News
COVID-19–associated coagulopathy
Early recognition and anticoagulation is imperative to improve clinical outcomes in COVID-19–associated coagulopathies.
From the Journals
COVID-19 pulmonary severity ascribed to coagulation differences
Feature
EHA and TIF explore how COVID-19 is affecting thalassemia and SCD patients
Feature
Can convalescent plasma treat COVID-19 patients?
How COVID-19 patients can receive convalescent plasma, who is eligible to donate, and early results of treatment.
News from the FDA/CDC
FDA okays emergency use of convalescent plasma for seriously ill COVID-19 patients
“It’s crucial that data be captured for every patient so that we really understand what safety and effectiveness looks like on as close to a real-...
From the Journals
Sickle cell patients with vitamin D deficiency prone to more ED visits, longer stays
Screening for vitamin D deficiency may show benefits, authors suggest.
Conference Coverage
After PCI, stopping antiplatelet therapy for surgery appears safe
NATIONAL HARBOR, MD. –
Conference Coverage
Fear drives activity changes in hemophilia patients